REVENUE STRATEGY - ABBOTT LABORATORIES

1. Abbott Laboratories won U.S. approval of a lower dose of the AIDS drug Kaletra in tablet form to treat children, the first step toward making the medicine available to 2.3 million children with the virus worldwide. The new tablets offer more flexibility in dosing. They can be taken with or without food and don't require refrigeration, an advantage in poorer countries.
2. In April, it cut the price of the drug to low and low-middle income nations by more than half, responding to pressure from the United Nations and Thailand's threat to make a generic version.

[Click here for full story at: BLOOMBERG.COM]